Contraindications for Albumin Infusions
Albumin infusion is absolutely contraindicated in patients with a history of allergic reactions to albumin, and should be avoided in those with congestive heart failure, renal insufficiency, or stabilized chronic anemia due to high risk of circulatory overload. 1
Absolute Contraindications
- History of allergic reaction to albumin - This is a specific and absolute contraindication 1
- Active congestive heart failure - These patients are at special risk for developing circulatory overload 1
Relative Contraindications (High-Risk Situations)
Cardiovascular and Renal Conditions
- Renal insufficiency - Increased risk of fluid overload and circulatory complications 1
- Stabilized chronic anemia - Special risk category for circulatory overload 1
- Hypervolemic states - Particularly in neonates and dialysis patients who cannot tolerate substantial fluid volumes 1
Clinical Scenarios Where Albumin Should NOT Be Used
The FDA label and recent guidelines explicitly identify situations where albumin administration is not warranted 1:
Chronic protein-losing conditions:
- Chronic nephrosis (albumin is promptly excreted with no clinical benefit) 1
- Chronic cirrhosis with hypoproteinemia alone 1
- Malabsorption syndromes 1
- Protein-losing enteropathies 1
- Pancreatic insufficiency 1
- Undernutrition 1
The 2024 ICTMG guidelines specifically recommend AGAINST albumin use in:
- Critically ill adults with thermal injuries or ARDS for volume replacement 2
- Critically ill adults receiving albumin with diuretics for extravascular fluid removal 2
- Preterm neonates with respiratory distress and low albumin levels 2
- Preterm neonates requiring volume replacement 2
- Patients on kidney replacement therapy for intradialytic hypotension 2
- Pediatric cardiovascular surgery patients 2
- Patients with cirrhosis and uncomplicated ascites 3
Important Clinical Caveats
Pulmonary edema risk: Recent evidence from the ATTIRE trial showed that albumin administration aimed at maintaining serum levels ≥3.0 g/dL resulted in higher rates of pulmonary edema compared to controls 3. This underscores the danger of aggressive albumin replacement in volume-sensitive patients.
Heart failure with hypoalbuminemia: A 2025 propensity-matched analysis found that albumin infusion in heart failure patients with serum albumin ≤2.9 g/dL was associated with increased in-hospital mortality and prolonged ICU/hospital stays 4. This represents emerging evidence that challenges traditional practice.
Nutritional supplementation: Albumin should never be used as a source of protein nutrition in any hypoproteinemic state - this is explicitly stated as inappropriate use 1.
Risk Assessment Algorithm
Before administering albumin, verify:
- No history of albumin allergy (absolute contraindication)
- No active heart failure (high risk)
- Adequate renal function or careful volume monitoring if impaired
- Not hypervolemic - assess jugular venous pressure, lung sounds, peripheral edema
- Indication is evidence-based - primarily cirrhosis complications (SBP, HRS, large-volume paracentesis >5L), not simple hypoalbuminemia
The fundamental principle is that hypoalbuminemia itself is not an indication for albumin replacement - treat the underlying disease process instead 1, 5, 6.